Skip to main content

Asciminib Hydrochloride

(as-KIH-mih-nib HY-droh-KLOR-ide)

This page contains brief information about asciminib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Scemblix
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Asciminib hydrochloride is approved to treat adults with:

¹This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that asciminib hydrochloride provides a clinical benefit in these patients.

Asciminib hydrochloride is also being studied in the treatment of other types of cancer.

More About Asciminib Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Asciminib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: